Log in to save to my catalogue

Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus

Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1623475751

Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus

About this item

Full title

Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus

Publisher

Cham: Springer International Publishing

Journal title

PharmacoEconomics, 2014-01, Vol.32 (1), p.15-27

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Background
Economic models are considered to be important, as they help evaluate the long-term impact of diabetes treatment. To date, it appears that no article has reviewed and critically appraised the cost-effectiveness models developed to evaluate new oral treatments [glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-...

Alternative Titles

Full title

Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1623475751

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1623475751

Other Identifiers

ISSN

1170-7690

E-ISSN

1179-2027

DOI

10.1007/s40273-013-0117-7

How to access this item